Funding / Entrepreneur
INVESTING Individual Investor Financial Adviser Institutional Investor FUNDING Entrepreneur Real Estate
Reading time: < 1 minute

Pelago (formerly Quit Genius)

22 Feb 2023 By aitanabc

About Pelago

Pelago is the world’s first digital clinic for treating nicotine, alcohol and opioid addictions.

The company formed in 2017 to prevent health problems before they arise by providing more effective addiction treatments.

It’s estimated that 40% of all cancers are linked to smoking tobacco. There are companies and treatments out there attempting to tackle the problem. But of current solutions, many have less than 1% usage rates. They’re mostly generic and phone-call based, and achieve quit rates of about 20%.

Pelago set out to change this and has since also applied its successful programme to alcohol and opioids. It replaces traditional telephone coaching with an entirely virtual service, including a personalised app, breath sensors and urine samples, and a dedicated counsellor.

The team has demonstrated a 53% quit rate for people using the app. This compares with the gold standard of one-to-one therapy at 27%.

Pelago is empowering people to overcome addictions. The aim is to free 100 million people from addictions that interfere with their lives, damage their health and, for some, cause unnecessary premature death.

Related articles

What next for European healthtech?
1 Sep 2023

What next for European healthtech?

Our recent report, The Resilience of Early-Stage European Healthtech, took a granular look at the sector. In this blog, Matt Vallin unpacks our predictions.
Written by Matthieu Vallin
Our Investment in Little Journey
18 Apr 2023

Our Investment in Little Journey

Read about investment in Little Journey, a digital eSupport platform that provides multi-faceted support to children and families before, during and after healthcare procedures and clinical trials.
Written by Joe Stringer